Company profile: Merck
1.1 - Company Overview
Company description
- Provider of biopharmaceutical medicines and vaccines for various diseases, driven by a mission to discover, develop, and provide innovative products and services that save and improve lives.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Merck
Omni Biopharma
HQ: United States
Website
- Description: Provider of Alpha-1 antitrypsin (AAT)-based therapeutics, developing alternative uses of AAT for various medical treatments and advancing recombinant forms of AAT for therapeutic applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Omni Biopharma company profile →
G7 Therapeutics
HQ: Switzerland
Website
- Description: Provider of proprietary approaches to stabilize G protein-coupled receptors (GPCRs), enabling novel structure-based drug development for designing highly selective small molecules or biologics targeting GPCRs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full G7 Therapeutics company profile →
Endacea
HQ: United States
Website
- Description: Provider of biopharmaceutical therapies targeting the A1 adenosine receptor, including L-97-1, an intravenous A1 adenosine receptor antagonist for sepsis and acute renal failure, and a mutant plasmid cDNA for cancer administered as an intratumor injection. Both programs are in the preclinical stage.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Endacea company profile →
Farmalider
HQ: Spain
Website
- Description: Provider of development, registration, licensing and manufacturing of generic pharmaceuticals, with two plants producing prescription, OTC and dietary supplement products in liquid, granulated and solid oral forms. Specializes in pain management, leading in ibuprofen and paracetamol in Spain. Services include formulation R&D, clinical trial batches, registration documentation, pharmacovigilance, and supply of generics in growing European markets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Farmalider company profile →
Genkyotex
HQ: Switzerland
Website
- Description: Provider of innovative drugs and platform technology that block NOX enzymes producing oxygen radicals to treat oxygen-radical mediated acute and chronic diseases, with improved specificity, safety, and efficacy over existing antioxidants therapy. Offerings include setanaxib and a NOX inhibitor platform.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genkyotex company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Merck
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Merck
2.2 - Growth funds investing in similar companies to Merck
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Merck
4.2 - Public trading comparable groups for Merck
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →